Symbols / KHRNF $0.00 +0.00% Khiron Life Sciences Corp.
KHRNF Chart
About
Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe. It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products. The company is also involved in the operation of health centers under the Zerenia and Dr. Zerenia brand names; and provision of medical education and training programs for health professionals. It sells its products in Colombia, Peru, Germany, the United Kingdom, Brazil, Uruguay, and Mexico. The company is headquartered in Bogota, Colombia.
Fundamentals
Scroll to Statements| Market Cap | 2.34K | Enterprise Value | 626.22K | Income | -30.66M | Sales | 16.14M | Book/sh | 0.09 | Cash/sh | 0.01 |
| Dividend Yield | — | Payout | 0.00% | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | 0.00 | P/B | 0.00 | P/C | — | EV/EBITDA | -0.04 | EV/Sales | 0.04 |
| Quick Ratio | 0.71 | Current Ratio | 2.02 | Debt/Eq | 9.46 | LT Debt/Eq | — | EPS (ttm) | -0.01 | EPS next Y | — |
| EPS Growth | — | Revenue Growth | -3.80% | Earnings | — | ROA | -20.79% | ROE | -74.68% | ROIC | — |
| Gross Margin | 41.34% | Oper. Margin | -103.55% | Profit Margin | -190.00% | Shs Outstand | 232.41M | Shs Float | 204.94M | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | 0.00 | 52W Low | 0.00 | Beta | 22.92 | Avg Volume | 0.00 |
| Volume | 15.04K | Target Price | — | Recom | None | Prev Close | $0.00 | Price | $0.00 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-0.68
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
- Khiron Life Sciences Stock Price Forecast. Should You Buy KHRNF? - StockInvest.us Fri, 04 Dec 2020 20
- Khiron Life Sciences Announces Closing of the Sale of Its European Business - Yahoo Finance Fri, 17 Nov 2023 08
- Your first trade for Tuesday, December 11 - CNBC ue, 11 Dec 2018 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2021-12-31 |
|---|---|---|
| Total Revenue |
|
12.79
|
| Operating Revenue |
|
12.79
|
| Cost Of Revenue |
|
6.42
|
| Reconciled Cost Of Revenue |
|
6.26
|
| Gross Profit |
|
6.37
|
| Operating Expense |
|
26.16
|
| Research And Development |
|
1.22
|
| Selling General And Administration |
|
23.99
|
| Selling And Marketing Expense |
|
2.64
|
| General And Administrative Expense |
|
21.35
|
| Salaries And Wages |
|
11.10
|
| Other Gand A |
|
10.25
|
| Total Expenses |
|
32.58
|
| Operating Income |
|
-19.79
|
| EBITDA |
|
-32.03
|
| Normalized EBITDA |
|
-18.14
|
| Reconciled Depreciation |
|
1.11
|
| EBIT |
|
-33.15
|
| Total Unusual Items |
|
-13.89
|
| Total Unusual Items Excluding Goodwill |
|
-13.89
|
| Special Income Charges |
|
-15.21
|
| Other Special Charges |
|
0.24
|
| Impairment Of Capital Assets |
|
14.97
|
| Net Income |
|
-33.13
|
| Pretax Income |
|
-33.59
|
| Net Non Operating Interest Income Expense |
|
-0.45
|
| Interest Expense Non Operating |
|
0.45
|
| Net Interest Income |
|
-0.45
|
| Interest Expense |
|
0.45
|
| Other Income Expense |
|
-13.36
|
| Other Non Operating Income Expenses |
|
0.53
|
| Gain On Sale Of Security |
|
1.31
|
| Tax Provision |
|
-0.47
|
| Tax Rate For Calcs |
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.19
|
| Net Income Including Noncontrolling Interests |
|
-33.13
|
| Net Income From Continuing Operation Net Minority Interest |
|
-33.13
|
| Net Income From Continuing And Discontinued Operation |
|
-33.13
|
| Net Income Continuous Operations |
|
-33.13
|
| Normalized Income |
|
-19.43
|
| Net Income Common Stockholders |
|
-33.13
|
| Diluted EPS |
|
-0.20
|
| Basic EPS |
|
-0.20
|
| Basic Average Shares |
|
164.52
|
| Diluted Average Shares |
|
164.52
|
| Diluted NI Availto Com Stockholders |
|
-33.13
|
| Depreciation Amortization Depletion Income Statement |
|
0.95
|
| Depreciation And Amortization In Income Statement |
|
0.95
|
| Line Item | Trend | 2021-12-31 |
|---|---|---|
| Total Assets |
|
42.27
|
| Current Assets |
|
23.77
|
| Cash Cash Equivalents And Short Term Investments |
|
8.92
|
| Cash And Cash Equivalents |
|
8.92
|
| Cash Financial |
|
8.92
|
| Receivables |
|
2.88
|
| Accounts Receivable |
|
2.88
|
| Gross Accounts Receivable |
|
3.38
|
| Allowance For Doubtful Accounts Receivable |
|
-0.50
|
| Inventory |
|
9.45
|
| Raw Materials |
|
0.75
|
| Work In Process |
|
8.23
|
| Finished Goods |
|
0.16
|
| Prepaid Assets |
|
2.52
|
| Total Non Current Assets |
|
18.50
|
| Net PPE |
|
13.56
|
| Gross PPE |
|
18.23
|
| Accumulated Depreciation |
|
-4.67
|
| Properties |
|
0.00
|
| Land And Improvements |
|
1.09
|
| Buildings And Improvements |
|
9.29
|
| Machinery Furniture Equipment |
|
4.38
|
| Construction In Progress |
|
0.95
|
| Other Properties |
|
2.53
|
| Goodwill And Other Intangible Assets |
|
4.94
|
| Goodwill |
|
4.08
|
| Other Intangible Assets |
|
0.87
|
| Total Liabilities Net Minority Interest |
|
8.95
|
| Current Liabilities |
|
7.72
|
| Payables And Accrued Expenses |
|
4.31
|
| Payables |
|
4.31
|
| Accounts Payable |
|
4.31
|
| Current Debt And Capital Lease Obligation |
|
1.52
|
| Current Debt |
|
1.52
|
| Other Current Borrowings |
|
1.52
|
| Current Deferred Liabilities |
|
0.10
|
| Other Current Liabilities |
|
1.78
|
| Total Non Current Liabilities Net Minority Interest |
|
1.23
|
| Long Term Debt And Capital Lease Obligation |
|
0.70
|
| Long Term Debt |
|
0.70
|
| Non Current Deferred Liabilities |
|
0.52
|
| Non Current Deferred Taxes Liabilities |
|
0.31
|
| Other Non Current Liabilities |
|
0.00
|
| Stockholders Equity |
|
33.33
|
| Common Stock Equity |
|
33.33
|
| Capital Stock |
|
146.45
|
| Common Stock |
|
146.45
|
| Share Issued |
|
179.26
|
| Ordinary Shares Number |
|
179.26
|
| Retained Earnings |
|
-116.81
|
| Gains Losses Not Affecting Retained Earnings |
|
3.69
|
| Other Equity Adjustments |
|
3.69
|
| Total Equity Gross Minority Interest |
|
33.33
|
| Total Capitalization |
|
34.03
|
| Working Capital |
|
16.06
|
| Invested Capital |
|
35.56
|
| Total Debt |
|
2.23
|
| Net Tangible Assets |
|
28.39
|
| Tangible Book Value |
|
28.39
|
| Other Inventories |
|
0.32
|
| Line Item | Trend | 2021-12-31 |
|---|---|---|
| Operating Cash Flow |
|
-20.40
|
| Cash Flow From Continuing Operating Activities |
|
-20.86
|
| Net Income From Continuing Operations |
|
-33.59
|
| Depreciation Amortization Depletion |
|
1.11
|
| Depreciation And Amortization |
|
1.11
|
| Other Non Cash Items |
|
-1.08
|
| Stock Based Compensation |
|
2.32
|
| Asset Impairment Charge |
|
15.50
|
| Operating Gains Losses |
|
-2.33
|
| Gain Loss On Investment Securities |
|
-2.33
|
| Change In Working Capital |
|
-2.33
|
| Change In Receivables |
|
2.31
|
| Changes In Account Receivables |
|
2.31
|
| Change In Inventory |
|
-1.44
|
| Change In Prepaid Assets |
|
-0.36
|
| Change In Payables And Accrued Expense |
|
-2.83
|
| Investing Cash Flow |
|
-2.09
|
| Cash Flow From Continuing Investing Activities |
|
-2.09
|
| Net PPE Purchase And Sale |
|
-1.74
|
| Purchase Of PPE |
|
-1.74
|
| Capital Expenditure |
|
-1.74
|
| Net Investment Purchase And Sale |
|
0.00
|
| Sale Of Investment |
|
0.00
|
| Net Other Investing Changes |
|
-0.34
|
| Financing Cash Flow |
|
10.89
|
| Cash Flow From Continuing Financing Activities |
|
10.89
|
| Net Issuance Payments Of Debt |
|
-0.11
|
| Repayment Of Debt |
|
-0.11
|
| Long Term Debt Payments |
|
-0.11
|
| Net Long Term Debt Issuance |
|
-0.11
|
| Net Common Stock Issuance |
|
11.00
|
| Common Stock Payments |
|
0.00
|
| Repurchase Of Capital Stock |
|
0.00
|
| Changes In Cash |
|
-11.59
|
| Effect Of Exchange Rate Changes |
|
-1.14
|
| Beginning Cash Position |
|
21.65
|
| End Cash Position |
|
8.92
|
| Free Cash Flow |
|
-22.14
|
| Common Stock Issuance |
|
11.00
|
| Issuance Of Capital Stock |
|
11.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|